Active Clinical Studies for Hematologic/Blood Cancers

Comprehensive Cancer Centers  runs Phase II and Phase III research studies for hematologic/blood cancers cancers:

A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
Study #: i2688 Phase: III
Contact Us: For information about this clinical study, Email Us, or use our form field.

Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
Study #: i2761 Phase: III
Contact Us: For information about this clinical study, Email Us, or use our form field.

A Phase 2 Open Label Study Investigating the Efficacy and Safety of Roxadustat (FG-4592) for Treatment of Anemia in Patients Receiving
Chemotherapy Treatment for Non-Myeloid Malignancies

Study #: i2767 Phase: II
Contact Us: For information about this clinical study, Email Us, or use our form field.

A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician’s Choice in Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis with Severe Thrombocytopenia (Platelets Counts <50,000/µL) (PAC203)
Study #: 19171 Phase: III
Contact Us: For information about this clinical study, Email Us, or use our form field.